A Phase 2 Study of MM-121 in Combination With Docetaxel or Pemetrexed Versus Docetaxel or Pemetrexed Alone in Patients With Heregulin Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer
The purpose of this study is to determine whether the combination of MM-121 plus docetaxel
or pemetrexed is more effective than docetaxel or pemetrexed alone in regards to OS in
patients with heregulin-positive NSCLC.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society